These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 34749565)
1. Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects. Mousa AM; Alhumaydhi FA; Abdellatif AAH; Abdulmonem WA; AlKhowailed MS; Alsagaby SA; Al Rugaie O; Alnuqaydan AM; Aljohani ASM; Aljasir M; Alwashmi ASS; Soliman KEA; Yosof MYR; Elsheikh SY; Babiker AY; Alsuhaibani SA; Hegazy AMS; Seleem HS Cutan Ocul Toxicol; 2022 Mar; 41(1):33-42. PubMed ID: 34749565 [TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice. Sun J; Zhao Y; Hu J PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622 [TBL] [Abstract][Full Text] [Related]
3. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
4. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis. Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197 [TBL] [Abstract][Full Text] [Related]
5. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
6. Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice. Shobeiri SS; Dashti M; Pordel S; Rezaee M; Haghnavaz N; Moghadam M; Ansari B; Sankian M Cytokine; 2023 Dec; 172():156406. PubMed ID: 37879125 [TBL] [Abstract][Full Text] [Related]
7. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice. Zhao K; Pu S; Sun L; Zhou D Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802 [TBL] [Abstract][Full Text] [Related]
9. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis. Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906 [TBL] [Abstract][Full Text] [Related]
10. An Emerging Role of Yang Y; Zhao Y; Lai R; Xian L; Lei Q; Xu J; Guo M; Xian D; Zhong J Oxid Med Cell Longev; 2022; 2022():5800586. PubMed ID: 35720176 [TBL] [Abstract][Full Text] [Related]
12. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice. Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845 [TBL] [Abstract][Full Text] [Related]
13. Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice. Chen HH; Lin CC; Tung YT; Chao YH; Huang WC; Lee PY Molecules; 2020 Apr; 25(8):. PubMed ID: 32316255 [TBL] [Abstract][Full Text] [Related]
14. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway. Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468 [TBL] [Abstract][Full Text] [Related]
15. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells. Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999 [TBL] [Abstract][Full Text] [Related]
16. Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-α/NF-κB axis mediated transactivation of IL-17A and IL-33 in keratinocytes. Yang Y; Zhang Y; Chen X; Su Z; Deng Y; Zhao Q J Ethnopharmacol; 2022 Jun; 292():115124. PubMed ID: 35183690 [TBL] [Abstract][Full Text] [Related]
17. Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent. Parmar KM; Jagtap CS; Katare NT; Dhobi M; Prasad SK Indian J Pharmacol; 2021; 53(2):125-131. PubMed ID: 34100396 [TBL] [Abstract][Full Text] [Related]
18. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282 [TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis. Li HJ; Wu NL; Lee GA; Hung CF Sci Rep; 2018 Apr; 8(1):6335. PubMed ID: 29679037 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model. Guillaume P; Rupp T; Froget G; Goineau S Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]